Duality Advisers, LP Intercept Pharmaceuticals, Inc. Transaction History

Duality Advisers, LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 02, 2022	SELL	$14.28 - $19.53 $731,078 - $999,857	-51,196 Closed	0 $0
Q3 2021 Nov 08, 2021	SELL	$12.99 - $20.47 $679,000 - $1.07 Million	-52,271 Reduced 50.52%	51,196 $760,000
Q2 2021 Aug 09, 2021	SELL	$15.46 - $24.5 $34,027 - $53,924	-2,201 Reduced 2.08%	103,467 $2.07 Million
Q1 2021 May 13, 2021	SELL	$19.33 - $37.75 $458,449 - $895,316	-23,717 Reduced 18.33%	105,668 $2.44 Million
Q4 2020 Feb 09, 2021	BUY	$24.48 - $42.47 $2.42 Million - $4.19 Million	98,685 Added 321.45%	129,385 $3.2 Million
Q3 2020 Nov 12, 2020	BUY	$39.09 - $53.44 $1.2 Million - $1.64 Million	30,700 New	30,700 $1.27 Million

1.04M

30K

5.9K

Ticker ICPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,127,400
Description
Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States, Europe, and Canada. The company markets Ocaliva, a farnesoid X receptor agonist used for the treatment of primary biliary cholangitis in combination wit...

Get notified when there are updates to the investment portfolio of Duality Advisers, LP, based on Form 13F filings with the SEC.

Stay updated on Duality Advisers, LP with notifications on news.